ProShares Ultra Nasdaq Biotechnology
- ETF
- Ticker BIB
- NASDAQ
Performance, volatility and drawdowns of ProShares Ultra Nasdaq Biotechnology since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $22,480. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −66.2% in 04/2025, measured from the peak in 02/2021. It took 65 months to get back to the old peak.
Factor profile
Monthly returns 12/2016 to 09/2026, measured against USA. The factors explain 52% of the variation.
- Market
- 1.33
- Size
- 1.03
- Value
- −0.78
- Profitability
- −0.62
- Low investment
- 0.60
- Momentum
- −0.18
How to read this: BIB moves more than the stock market (USA): when the market rises by 1%, the ETF rises by 1.33% on average. The ETF leans towards small companies, highly valued growth stocks and less profitable companies.
A value of 1 for the market means: when the market rises by 1%, the ETF rises by 1% on average. The other values show the lean towards small, cheaply valued, profitable, conservatively investing and recently strong stocks; bold where it is clear. Calculated with the Fama and French factors and momentum.
Annual returns
Best year 2025 at +59.2%, weakest 2022 at −28.8%. 4 of 9 full years were positive. * partial year.
Similar ETFs
Frequently asked questions
How has BIB performed since 11/2016?
$10,000 grew to $22,480 by 20 Nov 2026, which is +8.4% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is BIB?
Volatility was 38.1% per year, measured on monthly returns. The largest decline from a peak was −66.2%, with the low in 04/2025.
How does BIB compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, BIB returned +8.4% at 38.1%. The correlation of monthly returns was 0.64; 1 would mean they moved in lockstep.
What does BIB hold?
BIB holds 250 positions. The largest are ProShares GENIUS Money Market ETF, Amgen, Inc. and Vertex Pharmaceuticals, Inc.; the 10 largest together make up 28.0% of the fund (holdings as of 31 Aug 2026, according to the fund's filing with the SEC).
Which currency are the figures in?
In US dollars, the currency of the US listing.